Shuiping Tu

9.8k total citations · 2 hit papers
39 papers, 2.7k citations indexed

About

Shuiping Tu is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Shuiping Tu has authored 39 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Shuiping Tu's work include Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Colorectal Cancer Treatments and Studies (5 papers). Shuiping Tu is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Colorectal Cancer Treatments and Studies (5 papers). Shuiping Tu collaborates with scholars based in China, United States and United Kingdom. Shuiping Tu's co-authors include Timothy C. Wang, Shigeo Takaishi, Sophie S.W. Wang, Shanisha Gordon, Tomoyuki Okumura, Yutaka Shimada, Wataru Shibata, Tamas A. Gonda, James G. Fox and Barry Rickman and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Gastroenterology.

In The Last Decade

Shuiping Tu

39 papers receiving 2.7k citations

Hit Papers

Identification of Gastric Cancer Stem Cells Using the Cel... 2008 2026 2014 2020 2009 2008 250 500 750

Peers

Shuiping Tu
Shuiping Tu
Citations per year, relative to Shuiping Tu Shuiping Tu (= 1×) peers Yoichi Matsuo

Countries citing papers authored by Shuiping Tu

Since Specialization
Citations

This map shows the geographic impact of Shuiping Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuiping Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuiping Tu more than expected).

Fields of papers citing papers by Shuiping Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuiping Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuiping Tu. The network helps show where Shuiping Tu may publish in the future.

Co-authorship network of co-authors of Shuiping Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuiping Tu. A scholar is included among the top collaborators of Shuiping Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuiping Tu. Shuiping Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Baiwen, Lina He, Cong Zhou, et al.. (2024). A pancancer analysis of the clinical and genomic characteristics of multiple primary cancers. Scientific Reports. 14(1). 2367–2367. 6 indexed citations
2.
Wang, Jianzheng, Shuiping Tu, Vivek P. Chavda, Zhe‐Sheng Chen, & Xiaobing Chen. (2022). Successes and failures of immunotherapy for gastric cancer. Drug Discovery Today. 27(11). 103343–103343. 6 indexed citations
3.
Wang, Jianzheng, Baiwen Zhang, Huifang Lv, et al.. (2022). The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer. Frontiers in Oncology. 12. 924149–924149. 8 indexed citations
4.
Zhou, Cong, Xiaojiao Cheng, & Shuiping Tu. (2021). Current status and future perspective of immune checkpoint inhibitors in colorectal cancer. Cancer Letters. 521. 119–129. 22 indexed citations
5.
Wang, Jianzheng, Qingli Li, Huifang Lv, et al.. (2021). A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report. Frontiers in Oncology. 11. 671416–671416. 6 indexed citations
6.
Wang, Jianzheng, Qingli Li, Xiaojiao Cheng, et al.. (2020). <p>Bone Marrow-Derived Myofibroblasts Promote Gastric Cancer Metastasis by Activating TGF-β1 and IL-6/STAT3 Signalling Loop</p>. OncoTargets and Therapy. Volume 13. 10567–10580. 9 indexed citations
7.
Qin, Shao‐Lan, Yong Zhou, Jianjun Chen, et al.. (2018). Low levels of TSC22 enhance tumorigenesis by inducing cell proliferation in colorectal cancer. Biochemical and Biophysical Research Communications. 497(4). 1062–1067. 3 indexed citations
8.
Yang, Chung S., Xiaoxin Chen, & Shuiping Tu. (2016). Etiology and Prevention of Esophageal Cancer. PubMed. 3(1). 3–16. 68 indexed citations
9.
Zhu, Li, Jia Shi, Jiacheng Lin, et al.. (2016). Crosstalk between bone marrow-derived myofibroblasts and gastric cancer cells regulates cancer stemness and promotes tumorigenesis. Oncogene. 35(41). 5388–5399. 28 indexed citations
10.
Jin, Huanyu, Hong Wang, Gary Lu, et al.. (2014). NNK-Induced DNA Methyltransferase 1 in Lung Tumorigenesis in A/J Mice and Inhibitory Effects of (−)-Epigallocatechin-3-Gallate. Nutrition and Cancer. 67(1). 167–176. 32 indexed citations
11.
Tu, Shuiping, Govind Bhagat, Guanglin Cui, et al.. (2011). Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice. Cancer Cell. 19(1). 154–154. 2 indexed citations
12.
Ben, Qiwen, et al.. (2011). Serum Interleukin-33 Levels in Patients with Gastric Cancer. Digestive Diseases and Sciences. 56(12). 3596–3601. 112 indexed citations
13.
Dong, Wenjie, et al.. (2009). Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer. Biochemical and Biophysical Research Communications. 387(1). 132–138. 18 indexed citations
14.
Jiang, Le, Tamas A. Gonda, Mary V. Gamble, et al.. (2008). Global Hypomethylation of Genomic DNA in Cancer-Associated Myofibroblasts. Cancer Research. 68(23). 9900–9908. 123 indexed citations
15.
Wang, Xiaofei, Jérôme Kerzerho, Olivier Adotévi, et al.. (2008). Comprehensive Analysis of HLA-DR- and HLA-DP4-Restricted CD4+ T Cell Response Specific for the Tumor-Shared Antigen Survivin in Healthy Donors and Cancer Patients. The Journal of Immunology. 181(1). 431–439. 35 indexed citations
16.
Tu, Shuiping, Govind Bhagat, Guanglin Cui, et al.. (2008). Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice. Cancer Cell. 14(5). 408–419. 659 indexed citations breakdown →
17.
Tu, Shuiping, Govind Bhagat, Guanglin Cui, et al.. (2008). Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice. Cancer Cell. 14(6). 494–494. 3 indexed citations
18.
Tu, Shuiping, L J Alfred, Guanglin Cui, et al.. (2007). Gastrin regulates the TFF2 promoter through gastrin-responsivecis-acting elements and multiple signaling pathways. American Journal of Physiology-Gastrointestinal and Liver Physiology. 292(6). G1726–G1737. 35 indexed citations
19.
Gong, Zihua, et al.. (2002). Mechanisms of Chinese Herb Emodin and Somatostatin Analogs on Pancreatic Regeneration in Acute Pancreatitis in Rats. Pancreas. 25(2). 154–160. 29 indexed citations
20.
Yuan, Yaozong, et al.. (2001). Effects and mechanisms of somatostatin analogs on apoptosis of pancreatic acinar cells in acute pancreatitis in mice. Journal of Gastroenterology and Hepatology. 16(6). 683–688. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026